Bearnot H R, Glickman R M, Weinberg L, Green P H, Tall A R
J Clin Invest. 1982 Jan;69(1):210-7. doi: 10.1172/jci110432.
The effect of biliary diversion on intestinal apolipoprotein (apoA)-I and high density lipoprotein formation was studied in mesenteric lymph fistula rats. Bile diversion was produced by an exteriorized catheter that allowed interruption and reconstitution of the enterohepatic circulation. Bile diversion reduced lymph cholesterol output from 0.47+/-0.05 mumol/h to 0.17+/-0.03 mumol/h (P < 0.025), and lymph triglyceride output from 3.6+/-0.3mumol/h to 0.6+/-0.05 mumol/h (P < 0.025) after 24 h. This was due to depletion of lymph chylomicrons and very low density lipoprotein (VLDL). Despite the reduced lipid outputs, lymph apoA-I output was maintained during biliary diversion (basal: 119+/-15 mug/h; diverted 140+/-20 mug/h, n = 12). During biliary diversion, high density lipoprotein (HDL) were maintained in mesenteric lymph as shown by lipoprotein and immunoelectrophoresis. Bile diversion altered the lipid composition of lymph HDL. Bile-diverted lymph HDL was depleted in total cholesterol and has a greater phospholipid/cholesterol ester ratio than basal lymph HDL. Lymph HDL contained discoidal particles when examined by negative stain electron microscopy. Bile diversion was associated with a reduction in the size of discoidal HDL particles (basal, nondiverted, 165+/-7A (n = 112) compared with diverted 126+/-5A (n = 98, P < 0.025). Experiments were then carried out to determine the source of the apoA-I and HDL found in lymph from bile-diverted animals. The transfer of HDL from plasma into lymph was determined by the intravenous infusion of (125)I-apoA-I labeled HDL into lymph fistula rats. In both nonbile-diverted and diverted rats, the specific activity of apoA-I in the HDL fraction of lymph was 23% of the specific activity of apoA-I in plasma HDL, indicating that the major portion (75%) of mesenteric lymph apoA-I did not come from plasma filtration. In other experiments the intraduodenal infusion of [(3)H]leucine to bile fistula, lymph fistula rats resulted in relative fivefold increase in the specific activity in apoA-I in lymph HDL when compared with the specific activity of apoA-I in plasma HDL from the same animal. We conclude that intestinal apoA-I secretion is maintained during biliary diversion and that synthesis of this apoprotein occurs in the absence of chylomicron formation. We also conclude that discoidal HDL are present in mesenteric lymph despite reduced triglyceride absorption and secretion into lymph.
在肠系膜淋巴瘘大鼠中研究了胆汁转流对肠道载脂蛋白(apoA)-I和高密度脂蛋白形成的影响。通过外置导管实现胆汁转流,该导管可中断和重建肠肝循环。胆汁转流24小时后,淋巴胆固醇输出量从0.47±0.05μmol/h降至0.17±0.03μmol/h(P<0.025),淋巴甘油三酯输出量从3.6±0.3μmol/h降至0.6±0.05μmol/h(P<0.025)。这是由于淋巴乳糜微粒和极低密度脂蛋白(VLDL)减少所致。尽管脂质输出减少,但在胆汁转流期间淋巴apoA-I输出量保持稳定(基础值:119±15μg/h;转流后:140±20μg/h,n = 12)。脂蛋白和免疫电泳显示,在胆汁转流期间,肠系膜淋巴中的高密度脂蛋白(HDL)保持稳定。胆汁转流改变了淋巴HDL的脂质组成。胆汁转流的淋巴HDL总胆固醇含量减少,磷脂/胆固醇酯比值高于基础淋巴HDL。通过负染电子显微镜检查发现,淋巴HDL含有盘状颗粒。胆汁转流与盘状HDL颗粒尺寸减小有关(基础值,未转流,165±7Å(n = 112),转流后为126±5Å(n = 98,P<0.025)。随后进行实验以确定胆汁转流动物淋巴中apoA-I和HDL的来源。通过向淋巴瘘大鼠静脉注射(125)I-apoA-I标记的HDL来测定HDL从血浆向淋巴的转移。在未转流和转流的大鼠中,淋巴HDL部分中apoA-I的比活性均为血浆HDL中apoA-I比活性的23%,这表明肠系膜淋巴apoA-I的主要部分(75%)并非来自血浆滤过。在其他实验中,向胆汁瘘、淋巴瘘大鼠十二指肠内注射[(3)H]亮氨酸,与同一动物血浆HDL中apoA-I的比活性相比,淋巴HDL中apoA-I的比活性相对增加了五倍。我们得出结论,在胆汁转流期间肠道apoA-I分泌保持稳定,并且这种载脂蛋白的合成在无乳糜微粒形成的情况下发生。我们还得出结论,尽管甘油三酯吸收和向淋巴的分泌减少,但肠系膜淋巴中仍存在盘状HDL。